Tetrahydrofuran → 2-{1-[4-(6-phenyl-pyrazolo[1,5-a]pyrimidin-5-yl)-benzyl]-piperidin-4-yl}-3H-imidazo[4,5-c]pyridine
反応式
[NH:1]1[CH2:6][CH2:5][CH:4]([C:7]2[NH:15][C:10]3[CH:11]=[N:12][CH:13]=[CH:14][C:9]=3[N:8]=2)[CH2:3][CH2:2]1.[C:16]1([C:22]2[C:23]([C:31]3[CH:38]=[CH:37][C:34]([CH:35]=O)=[CH:33][CH:32]=3)=[N:24][C:25]3[N:26]([N:28]=[CH:29][CH:30]=3)[CH:27]=2)[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1.[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+].C1COCC1>C(O)(=O)C>[C:16]1([C:22]2[C:23]([C:31]3[CH:32]=[CH:33][C:34]([CH2:35][N:1]4[CH2:2][CH2:3][CH:4]([C:7]5[NH:15][C:10]6[CH:11]=[N:12][CH:13]=[CH:14][C:9]=6[N:8]=5)[CH2:5][CH2:6]4)=[CH:37][CH:38]=3)=[N:24][C:25]3[N:26]([N:28]=[CH:29][CH:30]=3)[CH:27]=2)[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
252 mg (1.06 mmol) 2-piperidine-4-yl-3H-imidazo[4,5-c]pyridine and 250 mg (0.84 mmol) 4-(6-phenylpyrazolo[1,5-a]pyrimidin-5-yl)benzaldehyde were reacted as described in example 12.0. Additional NaBH(OAc)3 has been added after one, three and five hours (two equivalents each) and the reaction mixture has been stirred overnight at room temperature. Since the reaction has not been complete, 20 mL THF and 10 mL acetic acid were added. Another two equivalents of NaBH(OAc)3 were added. Because after one hour stirring at room temperature the reaction has not changed additional 126 mg 2-piperidine-4-yl-3H-imidazo[4,5-c]pyridine and another two equivalents of NaBH(OAc)3 were added. The reaction has been worked up after stirring at room temperature for 70 hours. After purification 28 mg of the desired material has been obtained.
後処理
- stirringBecause after one hour stirring at room temperature the reaction
- stirringafter stirring at room temperature for 70 hours
- customAfter purification 28 mg of the desired material
- customhas been obtained
出典と根拠
- ORDレコード
- ord-4a552c98376c42ea86bd641b2c3fd202
- 出典データセット
- uspto-grants-2015_02
- 特許番号
- US08957064B2
反応ノート
読み込み中…